Article | April 30, 2024

Shifting The Approach: 4 Strategies For ICH E6(R3) Implementation

Documentation Traps

In May 2023, a new draft of the ICH Harmonised Guideline for Good Clinical Practice (GCP) ICH E6 (R3) was released for public consultation. Significant changes have been applied to ICH E6(R2), published in 2016, to arrive at the ICH E6(R3) draft. Those changes span three key areas — data governance, computer system validation, and oversight activities — all interwoven with RBQM.

In addition to codifying some best practices, R3 suggests sponsors take a proportionate approach to identifying and managing areas of risk — setting acceptable ranges for each risk and, by evaluating deviations to those thresholds, identifying trends. The aim is to guide companies in proactively addressing potential problem areas, improving clinical trial quality.

It is critical to acknowledge that implementation will be different for every organization. Seeking generic answers from partners or regulators about what is critical to quality misses the concept of RBQM, which are protocol-specific. Organizations must be thinking about the elements most important to protecting patients and preserving trial data integrity within their specific project.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene